The global Leiomyosarcoma (LMS) Treatment Market is on a path of sustained expansion, fueled by increasing global incidence of soft tissue sarcomas, advancements in personalized oncology, and a strong pipeline of targeted therapies. Leiomyosarcoma is a rare and aggressive form of cancer that arises from smooth muscle cells, necessitating specialized and often complex treatment...